Securing an Oxford science park for one of Europe’s leading knowledge economy investors
Kadans Science Partner
Abingdon Science Park is recognised as an innovative research and development location within the Oxford science and technology cluster. With plans to expand the Park, Kadan’s acquisition of the scheme will help to cement the science and technology industry within Oxfordshire and plays a crucial role in supporting the UK as a global exporter of R&D innovation post-Brexit.
The Quadrant, located on Abingdon Science Park, is home to companies including a world-leading cancer gene therapy company and data science firms. The work taking place on the park is boosting the science and tech industry across the Oxford to Cambridge Arc.
The Quadrant was acquired from Addington Capital, an investment management firm, for £13.475m and a net yield of 6.7%, securing an advantageous deal for both parties.
Kadans’ deepening interest to secure exposure to the UK’s science and tech sector proves that the Oxford to Cambridge Arc is the place to invest. As part of the deal, Kadans also bought 1.59 acres of land with planning permission for another 20,000 sq ft of laboratory and office space.